Davos: another milestone in global efforts to control cancer

anna portrait  picWorld leaders from governments, industry and civic society will gather in Davos next week to discuss how to respond to some of the most pressing issues facing the world today.

It is the annual meeting of the World Economic Forum, and this year the question of how to stem the rising tide of suffering and death from cancer will be on the agenda for the first time.

Two sessions are scheduled.

The first is an interactive dinner session on the Friday evening (Jan 23rd), titled: Cancer, Pathway to a Cure – What are the breakthroughs in cancer prevention and therapy?

This session offers an opportunity to ask questions about whether the research, development and regulatory “ecosystem” that we are relying on to deliver a cure for cancer is really fit for purpose. Where is the current succession of therapies – many using similar approaches to deliver incremental benefit at ever higher costs – really taking us? How can we reconfigure the business model to promote more innovative, ambitious approaches that can overcome the problem of drug resistance?

The second is a working session on the Saturday morning (Jan 24th), titled: Globalisation of Non-Communicable Diseases.

With governments across the world already committed to reducing preventable deaths from non-communicable diseases including cancer by 25% by 2025 (65th World Health Assembly, 2012), this session offers a welcome opportunity to put on the table the bold actions that must be taken at national and international level if governments are to have any chance of delivering on the commitments they made.

davos image

Doubtless there will be many Davos participants who will bring their own agendas to the cancer sessions. Among them will be Franco Cavalli, chair of the World Oncology Forum – a gathering of leading cancer researchers, clinicians, and policy makers, convened by ESO in 2012 and 2014, in collaboration with The Lancet, that has already spelt out the bold actions that are urgently needed at national and international level to turn the tide on cancer.

These actions are defined in the Stop Cancer Now! appeal and two more detailed appeals, which fit neatly in with the two Davos sessions, on “Speed up progress towards a cure”, and “Treat the treatable”. Cavalli, who played a major role in getting cancer onto the Davos agenda, will be arguing strongly for these policies at the two cancer sessions.

Davos is traditionally important as a forum where constructive conversations can take place between specialists – eg from the world of cancer – who have a deep understanding of a particular problem, and people who have the power and responsibility to take the action required to find solutions.

This year, it is an opportunity to get the message across to world leaders that “business as usual” is not an option in the face of a cancer epidemic that is costing the world $2 trillion each year, and to begin to turn the policies that the cancer community has been calling for into actionable items on the agendas that matter.

Wof image

2 thoughts on “Davos: another milestone in global efforts to control cancer

  1. Ahmed Elzawawy

    The Fourth Way
    A proposal for a brain storming thinking. A vision for a “ Fourth Way”. By: Ahmed Elzawawy
    http://www.icedoc.org & http://www.icedoc.net

    Among multiple factors, the main obvious cause for the shortage of essential cancer drugs and drugs generics in The USA is economic and particularly the lack of incentives for production. More scientific explorations and studies are needed. The aim should be toward the economical sustainability and affordability of better value cancer and not whether the drug is brand or generics.
    Searching for solutions for a problem with complexities like the shortage of cancer drugs generics in the USA opens broader view for the underlying matters in the USA and the world. Hence, this could give a clue and a model for other issues in the world and in all aspects of life that have economic elements. .
    The floating choices for any economic system along the last two centuries, lie in a predetermined way for the whole policy and economic issues for a given country. It could be fixed around either:
    a) We let the market work freely (Unlimited Liberalism and historical older form older of capitalism).
    b) or complete public-governmental- control and ownership.( The historical Marxism) .
    c) or Variable forms of a third way in between.
    We think that it is the time to make reflections and to propose The Fourth Way”.
    It seems that the notions of liberals markets and economy of today as well as all the older systems and economic ideologies would change. The next generation would see a newer flexible system and freedom of thoughts that could be a new liberalism aiming for the better of all and to consider the human aspects, continuous evolution, and the increase -as most as possible- of the numbers of winners in a scientific way.
    As an application in of the Fourth way the field of oncology; economic sustainability of better value cancer care and moon shots progress in science are hoped..
    We summarize our proposal of “The Fourth Way” as
    1) First, not be limited by any predetermined economic policy or theory.
    2) Identification of our goals, aims and objectives
    3) Strategies that reflect open thoughts and the hopes.
    4) To adopt flexible tactics, to use what is available from the revolution of information and innovative ideas that could realize your goals, and to consider in realistic way the interests and the motivation of stakeholders. Science is the way..
    5) To be human beings centered and to consider quality of life and the social and economic dignity of human beings.
    6) Everything should be legal and scientific and to consider the humanitarian aspects
    7) To consider how to make economic sustainability for any solution or a policy.
    8) there are a place under the sun for all , hence It is a win-win scientific approach for all stakeholders and to maintain economic and scientific progress. .
    In everything, war against each other is not a long term solution, but using minds smartly and our proposed concept of “The Fourth Way” could give insight not only for the problem of shortage of availability of essential cancer drugs in The USA, but also a general vision for thinking for economic policies in the world.
    When we face multi-complicated problems in the world, then it is a time to think out of the box.
    It is a personal proposal. Hence, all should feel free to modify or to support.
    Once again, as I stated before about the Win-Win Scientific initiative
    http://www.icedoc.org/winwin.htm , despite of the humanitarian motivation , it is completely scientific initiative that calls for more researches, scientific evidences and innovative studies.
    Kindest regards to all in our world.
    Professor Ahmed Elzawawy
    http://www.icedoc.org & http://www.icedoc.net ,
    . ===================================
    Further citation for the ”Fourth Way”:
    -Elzawawy A, Kerr D. Variation in the availability of cancer drug generics in the United States of America. Ann Oncol 2013; 24 (suppl 5):v17-v22

  2. Marco Rudin

    To fulfill the points 7,8,9 and 10 of the “Stop Cancer Now” appeal published on World Cancer Day, February 4th 2013, (http://www.eso.net/pagine-interne/wof-stop-cancer-now.html), we need more transparency and we need to stop the conflicts of interests at WHO, governments, research institutes politicians and clinics. Starting from the WHO the sponsors have taken over the lead of research and control the scientists to develop only their products. The better alternatives are in fact excluded from science because of the conflict of interests.
    See: Paul Flynn MP, member of the Council of Europe Health Committee and Liliane Maury Pasquier, Switzerland, Chairperson of the Sub-Committee on Public Health of the Parliamentary Assembly of the Council of Europe (PACE) in Swiss TV:

    RSI – Falò – Il fantasma della pandemia – a cura di Serena Tinari, Isabelle Moncada (25 febbraio 2010)

    minuto 14:40, Liliane Maury Pasquier, Gravi conflitti d’interesse
    minuto 18:40: L’OMS viene controllata finanziariamente dall’industria tramite le PPP (PPP / Public-Private Partnership / Partenariato Pubblico Privato): hanno invitato la volpe nel pollaio…
    minuto 28:30: Paul Flynn, deputato EU, farà un rapporto sui gravi conflitti d’interesse nell’OMS (“The handling of the H1N1 pandemic: more transparency needed”, Report, Social Health and Family Affairs Committee, Rapporteur: Mr Paul FLYNN, United Kingdom, SOC, adopted in Paris on 4 June 2010)
    minuto 58:20, Dr. med. Franco Denti, presidente dell’Ordine dei Medici del Ticino: “il conflitto d’interesse [all'OMS] sicuramente c’è”
    minuto 1:17:20, il Farmacista Cantonale Giovan Maria Zanini mette in dubbio l’indipendenza dell’OMS a causa della sostituzione dei finanziamenti pubblici con quelli privati


Leave a Comment

Your email address will not be published. Required fields are marked *

14 + fifteen =

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>